Gao Shu-Ping, Zhang Xue, Zhang Li-Shun, Huang Yan-Ping, Liu Zhao-Sheng
Department of Pharmacy, The Second Hospital, Tianjin Medical University, Tianjin, 300070, China.
Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics (Theranostics), School of Pharmacy, Tianjin Medical University, Tianjin, 300070, China.
Anal Bioanal Chem. 2017 Jun;409(15):3741-3748. doi: 10.1007/s00216-017-0315-9. Epub 2017 Mar 25.
Polyhedral oligomeric silsesquioxane (POSS) was utilized to prepare imprinted polymer through reversible addition-fragmentation chain transfer polymerization (RAFT) successfully. The imprinted polymer was made with a mixture of RAFT agent, 4-vinylpyridine (4-VP), POSS monomer [PSS-(1-propylmethacrylate)-heptaisobutyl substituted, MA 0702], and ethylene glycol dimethacrylate (EDMA), with ketoprofen (KET) as template. The influence of polymerization variables, the amount of RAFT agent and POSS monomer, the ratio of KET to 4-VP, and the ratio of 4-VP to EDMA, were investigated on the retention factor and imprinting effect. The greatest imprinting factor of the RAFT agent-based POSS MIP was 15.2, about 1.5 times higher than the RAFT agent-free agent POSS MIP. The permeability, surface morphology, as well as pore size distribution of POSS MIP monoliths made with RAFT agent and without RAFT agent were also studied. The optimal MIP was applied to solid phase extraction for KET from commercial tablets. The mean recoveries of KET for RAFT-based POSS MIP was 85.2% with a relative standard deviation of 2.6%.
通过可逆加成-断裂链转移聚合(RAFT)成功地利用多面体低聚倍半硅氧烷(POSS)制备了印迹聚合物。该印迹聚合物由RAFT试剂、4-乙烯基吡啶(4-VP)、POSS单体[PSS-(1-甲基丙烯酸丙酯)-七异丁基取代物,MA 0702]和乙二醇二甲基丙烯酸酯(EDMA)的混合物制成,以酮洛芬(KET)为模板。研究了聚合变量、RAFT试剂和POSS单体的用量、KET与4-VP的比例以及4-VP与EDMA的比例对保留因子和印迹效果的影响。基于RAFT试剂的POSS MIP的最大印迹因子为15.2,比不含RAFT试剂的POSS MIP高约1.5倍。还研究了含RAFT试剂和不含RAFT试剂制备的POSS MIP整体柱的渗透性、表面形态以及孔径分布。将最佳的MIP应用于从市售片剂中固相萃取KET。基于RAFT的POSS MIP对KET的平均回收率为85.2%,相对标准偏差为2.6%。